Unexpected finding on [131I]iodine scintigraphy: Warthin tumor in a patient with toxic nodular goiter referred for radioiodine treatment

被引：0
|
作者：
Aulich, Aleksandra [1 ]
Cichocki, Pawel [1 ]
Stefanski, Borys [1 ]
Adamczewski, Zbigniew [1 ]
机构：
[1] Med Univ Lodz, Dept Nucl Med, Ul Czechoslowacka 8-10, PL-92216 Lodz, Poland
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2023年
关键词：
D O I：
10.20452/pamw.16616
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 31 条
  • [1] Unexpected 131I iodine scintigraphy finding
    Aulich, A.
    Stefanski, B.
    Adamczewski, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S817 - S817
  • [2] Definitive 131 Iodine treatment in patients with nodular toxic goiter
    Abdelrazek, S. S.
    Rogowski, F.
    Zonenberg, A.
    Szelachowska, M.
    Nikolajuk, A.
    Parfienczyk, A.
    Szumowski, P.
    Telejko, B.
    Siewko, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S353 - S353
  • [3] Radioiodine 131I Treatment for Large Nodular Goiter: Recombinant Human Thyrotropin Allows the Reduction of Radioiodine 131I Activity to Be Administered in Patients with Low Uptake
    Ceccarelli, Claudia
    Antonangeli, Lucia
    Brozzi, Federica
    Bianchi, Francesca
    Tonacchera, Massimo
    Santini, Pierina
    Mazzeo, Salvatore
    Bencivelli, Walter
    Pinchera, Aldo
    Vitti, Paolo
    THYROID, 2011, 21 (07) : 759 - 764
  • [4] The significance of serum thyroglobulin measurement before and after the treatment of toxic nodular goiter with 131I
    Bonefacic, Boris
    Crncic, Tatjana Bogovic
    Tomas, Maja Ilic
    Girotto, Neva
    Ivankovic, Svjetlana Grbac
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (04) : 344 - 349
  • [5] Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy
    Nygaard, B
    Faber, J
    Veje, A
    Hegedüs, L
    Hansen, JM
    THYROID, 1999, 9 (05) : 477 - 481
  • [6] I-131 TREATMENT OF DIFFUSE AND NODULAR TOXIC GOITER WITH OR WITHOUT ANTITHYROID AGENTS
    BLIDDAL, H
    HANSEN, JM
    ROGOWSKI, P
    JOHANSEN, K
    FRIIS, T
    SIERSBAEKNIELSEN, K
    ACTA ENDOCRINOLOGICA, 1982, 99 (04): : 517 - 521
  • [7] 131I treatment of toxic nodular goiter under combined thyrostatic-thyromimetic medication is at low risk of late hypothyroidism
    Paghera, B.
    Panarotto, M. B.
    Maira, G.
    Magri, G. C.
    Bertagna, F.
    Bosio, G.
    Rossini, P.
    De Agostini, A.
    Savelli, G.
    Lucchini, S.
    Giubbini, R.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (03): : 341 - 347
  • [8] The evaluation of radioiodine therapy 131I out come after five years in patient with non-toxic nodular goitre.
    Abdelrazek, S. S.
    Rogowski, F.
    Szumowski, P.
    Frackiel, M.
    Kraszynska, A.
    Kornas, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S224 - S224
  • [9] A CASE OF RADIOIODINE UPTAKE IN A DONOR GRAFT SITE FOLLOWING IODINE(131I) ABLATION TREATMENT - IN A PATIENT WITH PAPILLARY THYROID CANCER
    Calnan, D. K.
    Bartholomeusz, D.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 34 - 34
  • [10] The effects of the radioiodine therapy on toxic nodular goiter with bordering thyroid 131I uptake (RAIU), stimulated and non stimulated with single, low dose of recombinant human thyrotropin (rhTSH).
    Parfienczyk, A. A.
    Rogowski, F.
    Abdelrazek, S. S.
    Kiersnowska-Rogowska, B.
    Szumowski, P.
    Kociura-Sawicka, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S158 - S158
1234